Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2022 Filed Jun 10, 2022 21:44 UTC |
Treco Douglas ADirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $71.70 | $0.00 |
DisclosureSEC source: 0001209191-22-036053 · doc4.xml · derivative · entry 1 Treco Douglas A · CIK 0001688192 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Shares · 12,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:46 UTC |
Behbahani AliDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $71.70 | $0.00 |
DisclosureSEC source: 0001209191-22-036055 · doc4.xml · derivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Shares · 12,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:43 UTC |
High Katherine ADirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $71.70 | $0.00 |
DisclosureSEC source: 0001209191-22-036048 · doc4.xml · derivative · entry 1 High Katherine A · CIK 0001631248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Shares · 12,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:41 UTC |
Greene JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $71.70 | $0.00 |
DisclosureSEC source: 0001209191-22-036045 · doc4.xml · derivative · entry 1 Greene John · CIK 0001610732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Shares · 12,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:39 UTC |
George SimeonDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $71.70 | $0.00 |
DisclosureSEC source: 0001209191-22-036042 · doc4.xml · derivative · entry 1 George Simeon · CIK 0001595117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Shares · 12,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:37 UTC |
Fardis MariaDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,000 | $0.00 Strike: $71.70 | $0.00 |
DisclosureSEC source: 0001209191-22-036037 · doc4.xml · derivative · entry 1 Fardis Maria · CIK 0001559231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Shares · 24,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option was granted on June 9, 2022 with respect to 24,000 Common Shares with 100% of the shares vesting in 36 equal monthly installments. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:36 UTC |
Fleming Harold EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $71.70 | $0.00 |
DisclosureSEC source: 0001209191-22-036036 · doc4.xml · derivative · entry 1 Fleming Harold Edward · CIK 0001857250 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Shares · 12,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 21:35 UTC |
Bolzon Bradley J PhDDirector
|
GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $71.70 | $0.00 |
DisclosureSEC source: 0001209191-22-036031 · doc4.xml · derivative · entry 1 Bolzon Bradley J PhD · CIK 0001354345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Shares · 12,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option was granted on June 9, 2022 with respect to 12,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2022; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2023 Annual General Meeting of Shareholders. Read SEC document |
| May 23, 2022 Filed May 24, 2022 21:55 UTC |
Morrow Phuong KhanhChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $54.71 | $0.00 |
DisclosureSEC source: 0001209191-22-031705 · doc4.xml · derivative · entry 2 Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Shares · 90,000 shares Expires 2032-05-23 F3 · derivative.exercise_date: This option was granted on May 23, 2022 with respect to 90,000 Common Shares, with 25% of the shares vesting on May 23, 2023 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months. Read SEC document |
| May 23, 2022 Filed May 24, 2022 21:55 UTC |
Morrow Phuong KhanhChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 27,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031705 · doc4.xml · derivative · entry 1 Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,750 Underlying: Common Shares · 27,750 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · derivative.exercise_date: This restricted stock unit award was granted on May 23, 2022 with respect to 27,750 Common Shares, with (i) one quarter of the shares vesting on May 23, 2023, (ii) one quarter of the shares vesting on May 23, 2024, (iii) one quarter of the shares vesting on May 23, 2025, and (iv) one quarter of the shares vesting on May 23, 2026. F2 · derivative.expiration_date: This restricted stock unit award was granted on May 23, 2022 with respect to 27,750 Common Shares, with (i) one quarter of the shares vesting on May 23, 2023, (ii) one quarter of the shares vesting on May 23, 2024, (iii) one quarter of the shares vesting on May 23, 2025, and (iv) one quarter of the shares vesting on May 23, 2026. Read SEC document |
| March 14, 2022 Filed Mar 14, 2022 22:12 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Tax withholdingCommon Shares | 4,153 | $61.08 | $253,665.24 |
DisclosureSEC source: 0001209191-22-018613 · doc4.xml · nonDerivative · entry 4 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,279 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 14, 2022 Filed Mar 14, 2022 22:03 UTC |
Klein Lawrence OttoCBO & COO
|
Tax withholdingCommon Shares | 1,229 | $61.08 | $75,067.32 |
DisclosureSEC source: 0001209191-22-018611 · doc4.xml · nonDerivative · entry 4 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,797 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 14, 2022 Filed Mar 14, 2022 22:01 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Tax withholdingCommon Shares | 1,039 | $61.08 | $63,462.12 |
DisclosureSEC source: 0001209191-22-018609 · doc4.xml · nonDerivative · entry 4 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,429 F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:12 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018613 · doc4.xml · derivative · entry 6 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Shares · 9,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on March 11, 2021 with respect to 36,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025. F4 · derivative.expiration_date: This restricted stock unit award was granted on March 11, 2021 with respect to 36,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:12 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 9,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018613 · doc4.xml · nonDerivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:12 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Tax withholdingCommon Shares | 5,487 | $62.56 | $343,266.72 |
DisclosureSEC source: 0001209191-22-018613 · doc4.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,432 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:03 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018611 · doc4.xml · derivative · entry 6 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Shares · 3,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on March 11, 2021 with respect to 12,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025. F4 · derivative.expiration_date: This restricted stock unit award was granted on March 11, 2021 with respect to 12,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024 and (iv) one quarter of the shares vesting on March 11, 2025. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:03 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionCommon Shares | 3,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018611 · doc4.xml · nonDerivative · entry 3 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:03 UTC |
Klein Lawrence OttoCBO & COO
|
Tax withholdingCommon Shares | 1,883 | $62.56 | $117,800.48 |
DisclosureSEC source: 0001209191-22-018611 · doc4.xml · nonDerivative · entry 2 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,026 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:01 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018609 · doc4.xml · derivative · entry 6 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 Underlying: Common Shares · 2,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F5 · derivative.exercise_date: This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025. F5 · derivative.expiration_date: This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:01 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 2,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018609 · doc4.xml · nonDerivative · entry 3 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 22:01 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Tax withholdingCommon Shares | 1,321 | $62.56 | $82,641.76 |
DisclosureSEC source: 0001209191-22-018609 · doc4.xml · nonDerivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,218 F3 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 22:12 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 11,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018613 · doc4.xml · derivative · entry 5 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,833 Underlying: Common Shares · 11,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2020 with respect to 35,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2020 with respect to 35,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 22:12 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 11,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018613 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 22:03 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,584 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018611 · doc4.xml · derivative · entry 5 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,583 Underlying: Common Shares · 4,584 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2020 with respect to 13,750 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2020 with respect to 13,750 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 22:03 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionCommon Shares | 4,584 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018611 · doc4.xml · nonDerivative · entry 1 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 22:01 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 2,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018609 · doc4.xml · derivative · entry 5 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,833 Underlying: Common Shares · 2,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F4 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023. F4 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 22:01 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 2,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-018609 · doc4.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · balance_after: Includes 163 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:40 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
GrantRestricted Stock Units · Derivative | 15,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011836 · doc4.xml · derivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 Underlying: Common Shares · 15,300 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:40 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 34,200 | $0.00 Strike: $58.29 | $0.00 |
DisclosureSEC source: 0001209191-22-011836 · doc4.xml · derivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,200 Underlying: Common Shares · 34,200 shares Expires 2032-02-18 F1 · derivative.exercise_date: This option was granted on February 18, 2022 with respect to 34,200 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of March 18, 2022. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:44 UTC |
Smith BrendanChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 15,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011841 · doc4.xml · derivative · entry 2 Smith Brendan · CIK 0001857492 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 Underlying: Common Shares · 15,300 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:44 UTC |
Smith BrendanChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $58.29 | $0.00 |
DisclosureSEC source: 0001209191-22-011841 · doc4.xml · derivative · entry 1 Smith Brendan · CIK 0001857492 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 30,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: This option was granted on February 18, 2022 with respect to 30,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of March 18, 2022. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:43 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 53,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011840 · doc4.xml · derivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Shares · 53,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:43 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 115,000 | $0.00 Strike: $58.29 | $0.00 |
DisclosureSEC source: 0001209191-22-011840 · doc4.xml · derivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Shares · 115,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: This option was granted on February 18, 2022 with respect to 115,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of March 18, 2022. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:41 UTC |
Klein Lawrence OttoCBO & COO
|
GrantRestricted Stock Units · Derivative | 20,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011838 · doc4.xml · derivative · entry 2 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,400 Underlying: Common Shares · 20,400 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 20,400 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 20,400 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026. Read SEC document |
| February 18, 2022 Filed Feb 22, 2022 22:41 UTC |
Klein Lawrence OttoCBO & COO
|
GrantStock Option (Right to Buy) · Derivative | 46,200 | $0.00 Strike: $58.29 | $0.00 |
DisclosureSEC source: 0001209191-22-011838 · doc4.xml · derivative · entry 1 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,200 Underlying: Common Shares · 46,200 shares Expires 2032-02-18 F1 · derivative.exercise_date: This option was granted on February 18, 2022 with respect to 46,200 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of March 18, 2022. Read SEC document |
| December 20, 2021 Filed Dec 23, 2021 01:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,750 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001209191-21-070994 · doc4.xml · derivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,233 Underlying: Common Shares · 17,750 shares Expires 2025-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option was granted on September 10, 2015 with respect to 321,712 Common Shares with 120,640 of the shares vested on August 1, 2016, the first anniversary of employment commencement, and the remainder vested in equal 36 monthly installments thereafter. Read SEC document |
| December 20, 2021 Filed Dec 23, 2021 01:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 17,750 | $1.81 | $32,127.50 |
DisclosureSEC source: 0001209191-21-070994 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 01:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Tax withholdingCommon Shares | 37,818 | $69.17 | $2,615,871.06 |
DisclosureSEC source: 0001209191-21-068456 · doc4.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,335 F3 · kind: On December 3, 2019, the reporting person was granted 120,000 restricted stock units. On December 3, 2021, 80,000 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 01:00 UTC |
Klein Lawrence OttoCBO & COO
|
Tax withholdingCommon Shares | 11,185 | $69.17 | $773,666.45 |
DisclosureSEC source: 0001209191-21-068455 · doc4.xml · nonDerivative · entry 2 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,325 F3 · kind: On December 3, 2019, the reporting person was granted 40,000 restricted stock units. On December 3, 2021, 26,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 01:00 UTC |
Ho Tony WExecutive VP, Head of R&D
|
Tax withholdingCommon Shares | 12,607 | $69.17 | $872,026.19 |
DisclosureSEC source: 0001209191-21-068454 · doc4.xml · nonDerivative · entry 2 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,364 F3 · kind: On December 3, 2019, the reporting person was granted 40,000 restricted stock units. On December 3, 2021, 26,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 01:00 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Tax withholdingCommon Shares | 6,303 | $69.17 | $435,978.51 |
DisclosureSEC source: 0001209191-21-068453 · doc4.xml · nonDerivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,542 F3 · kind: On December 3, 2019, the reporting person was granted 20,000 restricted stock units. On December 3, 2021, 13,333 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 01:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 80,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-068456 · doc4.xml · derivative · entry 3 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Shares · 80,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · derivative.exercise_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. F1 · derivative.expiration_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 01:00 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 80,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-068456 · doc4.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 01:00 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 26,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-068455 · doc4.xml · derivative · entry 3 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 Underlying: Common Shares · 26,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · derivative.exercise_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. F1 · derivative.expiration_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 01:00 UTC |
Klein Lawrence OttoCBO & COO
|
Exercise / conversionCommon Shares | 26,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-068455 · doc4.xml · nonDerivative · entry 1 Klein Lawrence Otto · CIK 0001762583 · CBO & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 01:00 UTC |
Ho Tony WExecutive VP, Head of R&D
|
Exercise / conversionRestricted Stock Units · Derivative | 26,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-068454 · doc4.xml · derivative · entry 3 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,333 Underlying: Common Shares · 26,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · derivative.exercise_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. F1 · derivative.expiration_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 01:00 UTC |
Ho Tony WExecutive VP, Head of R&D
|
Exercise / conversionCommon Shares | 26,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-068454 · doc4.xml · nonDerivative · entry 1 Ho Tony W · CIK 0001713637 · Executive VP, Head of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 01:00 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 13,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-068453 · doc4.xml · derivative · entry 3 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Shares · 13,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · derivative.exercise_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. F1 · derivative.expiration_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. Read SEC document |
| December 03, 2021 Filed Dec 8, 2021 01:00 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 13,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-068453 · doc4.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022. F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.